M A Armstrong
Overview
Explore the profile of M A Armstrong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
1838
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Phillips J, Gardner B, McMenamin J, Becker L, Murphy E, Keohane C, et al.
Ir J Med Sci
. 2016 Aug;
154(6):244-50.
PMID: 27517581
No abstract available.
2.
Ween M, Armstrong M, Oehler M, Ricciardelli C
Crit Rev Oncol Hematol
. 2015 Jun;
96(2):220-56.
PMID: 26100653
Over 80% of ovarian cancer patients develop chemoresistance which results in a lethal course of the disease. A well-established cause of chemoresistance involves the family of ATP-binding cassette transporters, or...
3.
Roberts S, Zahnd E, Sufrin C, Armstrong M
J Perinatol
. 2014 Sep;
35(2):146-50.
PMID: 25233193
Objective: This study examined whether adopting a standardized prenatal substance use protocol (protocol) in a hospital labor and delivery unit reduced racial disparities in reporting to child protective services (CPS)...
4.
Goler N, Armstrong M, Taillac C, Osejo V
J Perinatol
. 2008 Jun;
28(9):597-603.
PMID: 18580882
Objective: To evaluate the impact of Early Start, an obstetric clinic-based prenatal substance abuse treatment program, on perinatal outcomes. Study Design: Subjects were 49 985 women who completed Prenatal Substance...
5.
Escobar G, McCormick M, Zupancic J, Coleman-Phox K, Armstrong M, Greene J, et al.
Arch Dis Child Fetal Neonatal Ed
. 2006 Apr;
91(4):F238-44.
PMID: 16611647
Background: Newborns of 30-34 weeks gestation comprise 3.9% of all live births in the United States and 32% of all premature infants. They have been studied much less than very...
6.
McBride W, Allen J, Armstrong M
Eur J Anaesthesiol
. 2006 Jan;
23(3):261-2.
PMID: 16430799
No abstract available.
7.
Escobar G, Greene J, Hulac P, Kincannon E, Bischoff K, Gardner M, et al.
Arch Dis Child
. 2005 Jan;
90(2):125-31.
PMID: 15665162
Aim: To analyse rehospitalisation of newborns of all gestations. Methods: A total of 33,276 surviving infants of all gestations born between 1 October 1998 and 31 March 2000 at seven...
8.
Armstrong M, Lieberman L, Carpenter D, Gonzales V, Usatin M, Newman L, et al.
Qual Manag Health Care
. 2003 Nov;
9(2):6-15.
PMID: 14598626
Maternal substance abuse is a serious problem with significant adverse effects to mothers, fetuses, and children. The Early Start Program provides pregnant women in a managed care organization with screening...
9.
Plumb J, Armstrong M, Duddy M, Mirakhur M, McQuaid S
Mult Scler
. 2003 Apr;
9(2):142-7.
PMID: 12708809
Multiple sclerosis (MS) has a wide spectrum of clinical courses, characterized by multifocal central nervous system (CNS) damage, postulated to be mediated by CNS antigen-specific T cells. Dendritic cells (DC),...
10.
Bedi A, McBride W, Armstrong M, Murray J, Fee J
Br J Anaesth
. 2002 Oct;
89(4):546-50.
PMID: 12393353
Background: Although almost inert chemically, xenon is not unreactive biologically. It interacts with receptors involved in the expression of cytokines and adhesion molecules. The effect of xenon on the immune...